Provided by Tiger Trade Technology Pte. Ltd.

ImmuCell

9.84
-0.2200-2.19%
Post-market: 9.840.00000.00%19:30 EDT
Volume:54.67K
Turnover:543.44K
Market Cap:89.01M
PE:113.50
High:10.06
Open:10.06
Low:9.76
Close:10.06
52wk High:12.10
52wk Low:4.52
Shares:9.05M
Float Shares:6.03M
Volume Ratio:1.05
T/O Rate:0.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0867
EPS(LYR):-0.1200
ROE:2.57%
ROA:6.25%
PB:2.84
PE(LYR):-82.00

Loading ...

ImmuCell (ICCC) Q2 2026 Earnings Call: Sales Rise 11.5%, Capacity Expansion Planned

TradingKey
·
Aug 15

ImmuCell Q2 Revenue Rises on Higher Distributor Volume, Price Realization

Reuters
·
Aug 14

ImmuCell Q2 FY26 Net Income More than Doubled to 1.84 Million; Revenue Rises 11.5% to 7.2 Million

Reuters
·
Aug 14

ImmuCell Q2 EPS $0.20 Up From $0.06 YoY, Sales $7.186M Up From $6.445M YoY

Benzinga Earnings
·
Aug 14

ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026

THOMSON REUTERS
·
Aug 14

ImmuCell Corporation Q2 EPS USD 0.2

THOMSON REUTERS
·
Aug 14

ImmuCell Updates Financial Calendar with Quarterly Results Release and Investor Call

Reuters
·
Aug 07

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026

GlobeNewswire
·
Aug 07

Immucell Q2 Product Sales Rise 11.5% to $7.2 Million on Preliminary Results

Reuters
·
Jul 10

Immucell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results

THOMSON REUTERS
·
Jul 10

ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results

GlobeNewswire
·
Jul 10

ImmuCell CEO Paul te Boekhorst buys 8,000 shares for $75,960

Reuters
·
Jun 22

ImmuCell shareholders approve 2025 stock option, incentive plan at annual meeting

Reuters
·
Jun 18

ImmuCell Earnings Call Highlights Record Growth Push

TIPRANKS
·
May 16

ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year

Reuters
·
May 15

ImmuCell Q1 FY26 net income rises 34.2% to $1.94 million; product sales climb 28.4% to $10.36 million

Reuters
·
May 15

ImmuCell Q1 EPS $0.21 Up From $0.16 YoY, Sales $10.357M Up From $8.067M YoY

Benzinga Earnings
·
May 15

ImmuCell Corporation Q1 EPS USD 0.21

THOMSON REUTERS
·
May 15

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026

THOMSON REUTERS
·
May 15

ImmuCell Reaches Settlement Agreement with Norbrook Laboratories

TIPRANKS
·
May 09